Quantbot Technologies LP Has $3.85 Million Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Quantbot Technologies LP grew its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 100.1% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 154,591 shares of the medical instruments supplier’s stock after purchasing an additional 77,341 shares during the period. Quantbot Technologies LP owned about 0.08% of DENTSPLY SIRONA worth $3,851,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Nuance Investments LLC grew its stake in shares of DENTSPLY SIRONA by 3.8% in the second quarter. Nuance Investments LLC now owns 10,879,916 shares of the medical instruments supplier’s stock valued at $271,019,000 after buying an additional 402,329 shares in the last quarter. Wellington Management Group LLP boosted its position in shares of DENTSPLY SIRONA by 21.1% during the 4th quarter. Wellington Management Group LLP now owns 8,138,253 shares of the medical instruments supplier’s stock worth $289,640,000 after acquiring an additional 1,419,503 shares in the last quarter. Cooke & Bieler LP boosted its position in shares of DENTSPLY SIRONA by 16.2% during the 2nd quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock worth $186,996,000 after acquiring an additional 1,046,105 shares in the last quarter. Generation Investment Management LLP boosted its position in shares of DENTSPLY SIRONA by 43.4% during the 4th quarter. Generation Investment Management LLP now owns 6,598,211 shares of the medical instruments supplier’s stock worth $234,830,000 after acquiring an additional 1,998,012 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its position in shares of DENTSPLY SIRONA by 5.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 6,266,781 shares of the medical instruments supplier’s stock worth $207,995,000 after acquiring an additional 343,915 shares in the last quarter. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Stock Down 0.8 %

XRAY opened at $26.08 on Tuesday. The company has a quick ratio of 0.87, a current ratio of 1.33 and a debt-to-equity ratio of 0.57. The stock has a market cap of $5.42 billion, a price-to-earnings ratio of -59.27, a PEG ratio of 1.22 and a beta of 1.00. DENTSPLY SIRONA Inc. has a twelve month low of $23.58 and a twelve month high of $37.60. The company’s 50-day moving average price is $25.42 and its two-hundred day moving average price is $28.01.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). The company had revenue of $984.00 million during the quarter, compared to analysts’ expectations of $993.61 million. DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The firm’s revenue was down 4.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.51 earnings per share. As a group, equities analysts expect that DENTSPLY SIRONA Inc. will post 1.99 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 11th. Shareholders of record on Friday, September 27th will be paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 2.45%. The ex-dividend date of this dividend is Friday, September 27th. DENTSPLY SIRONA’s payout ratio is -145.45%.

Wall Street Analysts Forecast Growth

XRAY has been the topic of a number of research analyst reports. Needham & Company LLC restated a “buy” rating and issued a $34.00 target price on shares of DENTSPLY SIRONA in a research report on Tuesday, August 20th. Barrington Research reissued an “outperform” rating and set a $38.00 target price on shares of DENTSPLY SIRONA in a research note on Monday, July 8th. Robert W. Baird decreased their price target on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research note on Monday, July 22nd. Stifel Nicolaus decreased their price target on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a research note on Thursday, July 18th. Finally, Evercore ISI decreased their target price on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday, July 9th. Five equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $33.44.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.